Yang et al. [26] researched that the activation of the JAK-STAT pathway can affect the sensitivity of lung cancer cells to targeted drugs and play a key role in the formation of lung cancer targeted therapy resistance. The gene discussed is SOAT1; the disease is lung cancer.